Watch LIVE the focusIR May Investor webinar with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHikma Pharmaceuticals Share News (HIK)

Share Price Information for Hikma Pharmaceuticals (HIK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2,002.00
Bid: 2,006.00
Ask: 2,008.00
Change: -10.00 (-0.50%)
Spread: 2.00 (0.10%)
Open: 2,014.00
High: 2,024.00
Low: 1,994.00
Prev. Close: 2,012.00
HIK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON BRIEFING: LSEG says Refinitiv savings bigger, ahead of schedule

Thu, 03rd Mar 2022 08:28

(Alliance News) - London Stock Exchange Group on Thursday said 2021 was a successful year following the acquisition of Refinitiv, leaving the stock exchange operator well positioned as a financial market infrastructure and data business.

For 2021, LSEG generated total income of GBP6.81 billion, up from a pro-forma GBP6.77 billion in 2020. Gross profit rose to GBP6.24 billion from GBP6.16 billion on the same basis. Adjusted pretax profit was GBP2.30 billion, up 27% from GBP1.81 billion. Statutory pretax profit was GBP987m, up from GBP492m.

LSEG declared a final dividend of 70 pence per share, a 27% increase in full year dividend to 95 pence per share, reflecting its strong performance in the year and confidence in outlook.

"The group has delivered a strong financial and operating performance in the first year following the successful completion of the acquisition of Refinitiv, with good revenue growth across all of our businesses. We are making excellent progress on integration and are on track to meet or exceed all the acquisition targets. We have established our position as a leading global market infrastructure and data business, and we carry good momentum into 2022," said Chief Executive Officer David Schwimmer.

LSEG said cost synergies following the Refinitiv acquisition were running ahead of target, with GBP151 million in annual run-rate achieved in 2021. It has identified an additional GBP50 million in cost synergies, raising its five-year target to at least GBP400 million.

LSEG shares were up 9.4% early Thursday.

Here is what you need to know at the London market open:

----------

MARKETS

----------

FTSE 100: called up 0.4% at 7,460.10

----------

Hang Seng: up 0.6% at 22,467.34

Nikkei 225: closed up 0.7% at 26,577.27

S&P/ASX 200: closed up 0.5% at 7,151.40

----------

DJIA: closed up 596.40 points, 1.8%, at 33,891.35

S&P 500: closed up 1.9% at 4,386.54

Nasdaq Composite: closed up 1.6% at 13,752.02

----------

EUR: down at USD1.1098 (USD1.1130)

GBP: up at USD1.3400 (USD1.3363)

USD: firm at JPY115.68 (JPY115.60)

Gold: up at USD1,929.01 per ounce (USD1,923.31)

Oil (Brent): up at USD116.98 a barrel (USD109.94)

(changes since previous London equities close)

----------

ECONOMICS AND GENERAL

----------

Thursday's key economic events still to come

0955 CET Germany services purchasing managers' index

1000 CET EU eurozone services PMI

1100 CET EU producer price index

1100 CET EU unemployment

1300 CET EU ECB meeting accounts

0930 GMT UK services PMI

0830 EST US initial jobless claims

0945 EST US services PMI

1000 EST US ISM report on business services PMI

1000 EST US Fed Chair Powell presents Monetary Policy Report to Congress

1030 EST US EIA weekly natural gas storage report

----------

Russian forces have taken the Black Sea port of Kherson in southern Ukraine, the first major city to fall after a string of setbacks for Moscow. Russia's invasion so far has been astonishingly badly managed, a blundering "disaster, through and through", US defence experts said. It is like Moscow "tripped over the doorframe on the way into the house," one expert said, citing food and fuel shortages, poor intelligence and planning. Ukraine's second city Kharkiv continues to come under heavy Russian shelling, with police and university buildings among the latest struck.

----------

Ratings agencies Fitch and Moody's slashed Russia's sovereign debt to "junk" status, or the category of countries at risk of not being able to repay their debt, a week after Moscow began its assault on Ukraine. Moody's downgraded the rating on Russian long-term debt from Baa3 to B3 subject to a further review over the West's sanctions against Russia, while Fitch lowered its rating from BBB to B, also with a negative outlook. "The multi-notch downgrade of Russia's ratings and maintaining the review for further downgrade were triggered by the severe sanctions that Western countries have imposed on Russia", including on its central bank and some large financial institutions, Moody's said in a statement. The agency also noted a "heightened risk of disruption" to sovereign debt repayment in the face of "severe and coordinated sanctions".

----------

China's service sector slowed at the slowest rate for six months in February, survey data showed, though businesses expressed a stronger optimism for the year ahead. The seasonally adjusted headline business activity index slipped to 50.2 in February from 51.4 in January, signalling only a marginal rise in services activity.

----------

Service providers in Ireland reported the fastest growth in new business in six years, as overall business activity hit a four-month high in February, according to survey results released by IHS Markit. The AIB services business activity index jumped to 61.8 points in February from 56.2 in January, as Covid-19 restrictions were lifted in Ireland. The reading was the highest in four months and well above the long-run average of 55.0 points. The month-on-month acceleration in growth was the sharpest on record, IHS Markit said. The strong services score lifted the AIB Ireland composite purchasing managers' index to 59.1 in February from 56.1 in January, overcoming a decline in the factory sector reading. On Tuesday, IHS Markit had said the manufacturing PMI score was 57.8 points last month, down from 59.4 in January.

----------

BROKER RATING CHANGES

----------

Morgan Stanley cuts Hikma Pharmaceutical to 'equal-weight' ('overweight') - price target 2,300 (2,800) pence

----------

JPMorgan resumes SSP with 'overweight'

----------

COMPANIES - FTSE 100

----------

Housebuilder Taylor Wimpey said it delivered a strong 2021 performance with results in line with its expectations. For 2021, it posted pretax profit GBP679.6 million, up from GBP264.4 million in 2020 on revenue of GBP4.28 billion, up from GBP2.79 billion. 2021 saw a 47% increase in UK completions including joint ventures to 14,087, up from 9,609 in 2020, driven by good build performance and strong demand. Taylor Wimpey declared a final dividend of 4.44 pence for 8.58p total, up from 4.14p in 2020. It also plans GBP150 million share buyback in 2022 to return excess cash. Looking ahead, the company continues to expect to deliver low single-digit year-on-year completions growth in 2022 and to make further progress towards 21% to 22% operating margin target. Its operating margin in 2021 was 19.3%, up from 10.8% in 2020. Taylor Wimpey expects 2022 year-end net cash to be around GBP600 million, depending on the timing of land payments. "With the opportunistic purchase of additional land over the last 18 months, our land pipeline leaves us well placed to accelerate high-quality, profitable volume delivery from 2023, generating additional value and compelling investor returns," said Chief Executive Officer Pete Redfern.

----------

CRH said 2021 was another year of record delivery for the Dublin-based building materials firm, with continued strong cash generation and profit growth. For 2021, CRH posted pretax profit of USD3.34 billion, doubled from USD1.66 billion in 2020 on revenue of USD30.98 billion, up 12% from USD27.59 billion. CRH generated record net cash flows from operating activities of USD4.2 billion in 2021, up from USD3.9 billion in 2020. CRH declared a final dividend of 98.0 US cents per share, resulting in a total dividend of 121.0 cents for the year, up from 115.0 cents in 2020. Looking ahead, CRH expects underlying demand and pricing backdrop to remain favourable in 2022 albeit against an inflationary input cost environment and continued supply chain challenges. Federal funding for infrastructure is underpinned by the passing of the USD1.2 trillion infrastructure package by the US Congress, while the US residential market is expected to continue to grow driven by robust demand, it added.

----------

Coca-Cola HBC revoked its 2022 financial guidance due to the conflict between Russia and Ukraine, two of its key sales territories. The soft drinks bottler noted that 20% of its 2021 volumes and earnings before interest and tax came from the two countries. It temporarily stopped product at its plant in Kyiv on February 24 and evacuated its employees. Coca-Cola HBC said it will use management actions to mitigate the headwinds outside its control and is ready to redeploy marketing spend and capital expenditure to other markets.

----------

Investment manager Schroders said pretax profit jumped by 25% in 2021 to GBP764.1 million from GBP610.5 million in 2020, as net income rose by 18% to GBP2.57 billion from GBP2.18 billion. Schroders hiked its annual dividend by 7.0% to 122.0 pence from 114.0p. "After a period of benign markets there is a risk that the current turbulence will be with us for some while," the company said.

----------

Thursday's shareholder meetings

Chemring Group PLC - AGM

Petro Matad Ltd - AGM

Zytronic PLC - AGM

----------

By Tom Waite; thomaslwaite@alliancenews.com

Copyright 2022 Alliance News Limited. All Rights Reserved.

More News
3 Jan 2023 09:25

Hikma launches version of Xyrem medicine in US for treating narcolepsy

(Alliance News) - Hikma Pharmaceuticals PLC on Tuesday said it launched an authorised generic version of the Xyrem sodium oxybate prescription medicine in the US for treating narcolepsy.

Read more
3 Jan 2023 09:24

LONDON BROKER RATINGS: Citigroup cuts Wizz Air; Redburn likes CRH

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning, Monday and late Friday:

Read more
3 Jan 2023 09:03

LONDON MARKET OPEN: Stocks jump in first session of 2023

(Alliance News) - Stock prices in London made a strong start to the new year on Tuesday, despite weak Chinese data and the UK suffering a fresh wave of rail strikes.

Read more
3 Jan 2023 07:58

LONDON BRIEFING: Stocks called higher; China factory sector shrinks

(Alliance News) - Stocks in London are expected to start a new year on the front foot on Tuesday, after a mixed session in Asia amid weak Chinese economic data.

Read more
3 Jan 2023 07:46

Hikma launches generic narcolepsy solution in US

(Sharecast News) - Hikma Pharmaceuticals has launched an authorised generic version of Jazz Pharmaceuticals' 'Xyrem 1', or sodium oxybate oral solution, it announced on Tuesday.

Read more
8 Dec 2022 09:48

LONDON BROKER RATINGS: JPMorgan cuts Travis Perkins; BofA likes IAG

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning:

Read more
6 Dec 2022 10:48

RBC Capital Markets starts Hikma at 'outperform'

(Sharecast News) - RBC Capital Markets initiated coverage of Hikma Pharmaceuticals on Tuesday at 'outperform' with a 1,750p price target.

Read more
6 Dec 2022 10:26

LONDON BROKER RATINGS: JPMorgan cuts Lloyds but raises Barclays

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
15 Nov 2022 12:10

Credit Suisse initiates coverage of Hikma at 'outperform'

(Sharecast News) - Credit Suisse has initiated coverage of Hikma Pharmaceuticals with an 'outperform' rating.

Read more
15 Nov 2022 09:58

LONDON BROKER RATINGS: Jefferies cuts Aston Martin to 'underperform'

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
14 Nov 2022 09:25

LONDON BROKER RATINGS: Credit Suisse cuts Ferrexpo to 'neutral'

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
8 Nov 2022 09:39

LONDON BROKER RATINGS: Peel cuts Persimmon; Liberum raises Hammerson

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
3 Nov 2022 11:17

Hikma Pharmaceuticals reiterates 2022 guidance as costs widen

(Alliance News) - Hikma Pharmaceuticals PLC on Thursday reiterated annual guidance for all three of its businesses, continuing to expect them to underperform against 2021 due to rising costs.

Read more
3 Nov 2022 11:08

With tighter purse strings, is parity less probable for the pound?

STOXX 600 down 1.1%

*

Read more
3 Nov 2022 09:28

Banks, insurance dodge carnage as real estate stocks sink

Welcome to the home for real-time coverage of markets brought to you by Reuters reporters. You can share your thoughts with us at .

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.